Article PDF
References
Stryer D, Bero LA. Characteristics of materials distributed by drug companies: an evaluation of appropriateness. J Gen Intern Med. 1996;11:575–83.
Kessler DA. Addressing the problem of misleading advertising. Ann Intern Med. 1992;116:950–1.
Wilkes MS, Doblin D, Shapiro M. Pharmaceutical advertisements in leading medical journals: experts’ assessments. Ann Intern Med. 1992;116:912–9.
Lane RM, Sweeney M, Henry J. Pharmacotherapy of the depressed patient with cardiovasular and/or cerebrovascular illness. Brit J Clin Pract. 1995;48:256–62.
Wolfe S. Drug advertisements that go straight to the hippocampus. Lancet. 1996;348:632.
IMS America, 1995, National Prescription Audit.
Manolio TA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med. 1995;155:829–37.
Patient pack prescribing and the provision of patient information leaflets. Drug Ther Bull. 1995;33:86–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wolfe, S.M. Why do american drug companies spend more than $12 billion a year pushing drugs? Is it education or promotion?. J Gen Intern Med 11, 637–639 (1996). https://doi.org/10.1007/BF02599033
Issue Date:
DOI: https://doi.org/10.1007/BF02599033